LadRx Corp (LADXD)

[drugmanrx]

Notice the new paths the company is taking and has to take going forward.

FDA provides a path to approval takes money.

CytRx also plans to discuss with the European Medicines Agency (EMA) a path to filing a Marketing Authorization Application (MAA) takes money.

The fact that the company has found some one to offer then 15 million at 50 cents a share speaks volumes for CYTR.

Please don't get caught up in the spin "How can they sell these shares at such a discount"

Remember it was April 18, 2017 that CYTR was trading in the 40 cent range which it has been stuck in for the prior 6 months. The 6 months prior to that it only traded in the 50 to 60 cent range.

A deal to get some one to invest 15 million dollars is not made over night. It usually takes weeks or months to reach an agreement. If you take that into consideration at 50 cents a share was it really a discount or actually a premium (above market price) paid for the stock.

Take solace that some one has enough faith in the company's success to risk 15 million dollars at 50 cents a share considering what CYTR has been trading at the past year.

It really wasn't that bad of a deal if it was necessary to get approval.